New mRNA vaccine could prevent melanoma from returning

An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, in a large, closely watched trial, pharmaceutical companies Moderna and Merck announced today.

See the original article at: Honolulu Star-Advertiser